A detailed history of Credit Suisse Ag transactions in Biolife Solutions Inc stock. As of the latest transaction made, Credit Suisse Ag holds 36,281 shares of BLFS stock, worth $733,964. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,281
Previous 35,950 0.92%
Holding current value
$733,964
Previous $584,000 15.24%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$15.35 - $18.82 $5,080 - $6,229
331 Added 0.92%
36,281 $673,000
Q4 2023

Feb 08, 2024

BUY
$8.99 - $16.86 $3,856 - $7,232
429 Added 1.21%
35,950 $584,000
Q3 2023

Nov 13, 2023

SELL
$10.81 - $22.96 $39,261 - $83,390
-3,632 Reduced 9.28%
35,521 $490,000
Q2 2023

Aug 11, 2023

BUY
$17.19 - $24.34 $181,096 - $256,421
10,535 Added 36.81%
39,153 $865,000
Q1 2023

May 10, 2023

BUY
$17.67 - $26.07 $159 - $234
9 Added 0.03%
28,618 $622,000
Q4 2022

Feb 13, 2023

SELL
$16.95 - $25.07 $26,899 - $39,786
-1,587 Reduced 5.26%
28,609 $520,000
Q3 2022

Nov 10, 2022

BUY
$14.64 - $26.7 $98,629 - $179,877
6,737 Added 28.72%
30,196 $687,000
Q2 2022

Aug 12, 2022

BUY
$10.54 - $24.2 $25,928 - $59,532
2,460 Added 11.71%
23,459 $323,000
Q1 2022

May 16, 2022

BUY
$20.81 - $37.29 $28,967 - $51,907
1,392 Added 7.1%
20,999 $477,000
Q4 2021

Feb 14, 2022

BUY
$32.99 - $58.55 $49,089 - $87,122
1,488 Added 8.21%
19,607 $732,000
Q3 2021

Nov 12, 2021

BUY
$42.03 - $60.5 $102,090 - $146,954
2,429 Added 15.48%
18,119 $767,000
Q2 2021

Aug 16, 2021

SELL
$29.51 - $44.62 $118,718 - $179,506
-4,023 Reduced 20.41%
15,690 $698,000
Q1 2021

May 14, 2021

SELL
$32.95 - $44.24 $141,223 - $189,612
-4,286 Reduced 17.86%
19,713 $709,000
Q4 2020

Feb 12, 2021

BUY
$27.5 - $45.75 $659,972 - $1.1 Million
23,999 New
23,999 $957,000

Others Institutions Holding BLFS

About BIOLIFE SOLUTIONS INC


  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $864M
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.